Efficacy of ICIs on patients with oncogene-driven non-small cell lung cancer: a retrospective study

Aim: The objective of our study was to assess the efficacy of immune checkpoint inhibitors (ICIs) on patients with non-small-cell lung cancer (NSCLC) harboring oncogenic alterations. Methods: We retrospectively enrolled patients with advanced non-squamous NSCLC who were treated with anti-PD-1-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Xiaojin, Du, He, Li, Jiayu, Yang, Menghang, Xiong, Anweng, Zhang, Haiping, Wu, Fengying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992587/
https://www.ncbi.nlm.nih.gov/pubmed/35582532
http://dx.doi.org/10.20517/cdr.2021.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992587/
https://www.ncbi.nlm.nih.gov/pubmed/35582532
http://dx.doi.org/10.20517/cdr.2021.85

Ejemplares similares